Search results
As Medicare Part D grows, so does need for fraud audits
BenefitsPRO· 19 hours agoCMS is required to audit the financial records of at least one-third of Part D plan sponsors...
Why is Medicare Part D’s premium so high? | Chattanooga Times Free Press
Chattanooga Times Free Press· 6 days agoIf I do not apply for a Medicare prescription drug plan, do I still have to pay the extra $33.30?...
Was President Biden correct in saying Medicare Part D will cap costs at $2,000 for drugs?
Austin American-Statesman via Yahoo News· 5 days agoJoe Biden Statement: Starting in 2025, "no matter what your total bills are for prescription drugs,”...
HHS to probe impact of integrated Medicare Part D plans - Business Insurance
Business Insurance· 4 days agoThe U.S. Health and Human Services Department Office of Inspector General will investigate the impact of vertically integrated Medicare Part D& ...
3 big changes coming to Medicare in 2025—and what they’ll mean for you
Fortune via Yahoo Finance· 4 days agoThe advice for people looking to enroll in Medicare Part D plans in 2025: Review your choices...
Why has my Medicare prescription drug premium increased?
Las Vegas Review-Journal· 22 hours agoThe rule for Medicare Part D’s additional IRMAA premium went into effect in 2011, and new Medicare...
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B
The National Law Review· 17 hours agoOn April 15, the Centers for Medicare & Medicaid Services (CMS) released a
Does Medicare pay for hearing aids?
CBS News· 17 hours agoFor those who live with mild to severe hearing loss, shopping for good quality hearing aids can be a headache. If you're over 65, you may be wondering if...
Wegovy could soon treat millions of Medicare patients
Quartz· 2 days agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
Feds open another PBM probe
Becker’s Hospital Review· 4 days ago"CMS is auditing vertically integrated Medicare Part D sponsors, including PBMs and payers, in response to concerns of inflated drug prices."
